14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Forecast

$0.130
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Mast Therapeutics, Inc Fund and on which exchange is it traded?
The symbol for Mast Therapeutics, Inc is MSTX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Mast Therapeutics, Inc Fund?
Mast Therapeutics, Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Mast Therapeutics, Inc Fund?
Mast Therapeutics, Inc Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mast Therapeutics, Inc Fund.

What's the current price of Mast Therapeutics, Inc Fund?
As of the end of day on the Jan 16, 2018, the price of an Mast Therapeutics, Inc (MSTX) share was $0.130.

What is the 52-week high and low for Mast Therapeutics, Inc Fund?
The 52-week high for Mast Therapeutics, Inc Fund is $0.170 and the 52-week low is $0.0960.
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT